Shaily Engineering Plastics Limited, a precision plastics manufacturer based in Gujarat, expanded its production capacity during the second quarter of the financial year 2025–26 with the installation of 19 new injection moulding machines. The company reported strong growth in its healthcare business, which contributed significantly to overall performance during the quarter.
According to a stock exchange filing dated 8 November 2025, the new equipment was added as part of Shaily’s ongoing capacity expansion programme across its seven manufacturing facilities in Gujarat — six dedicated to plastics and one to steel furniture. The key production sites include Halol for carbon steel and plastics, Rania for export-oriented and pharmaceutical production with ISO Class 8 cleanroom facilities, and Halol (GIDC) for automotive and engineering components.
The company now operates more than 200 injection moulding machines ranging from 35 tons to 1,000 tons, supported by automated and robotic production lines. Machine utilisation across facilities increased to 47.7 percent in the second quarter of financial year 2025–26 from 42.2 percent a year earlier, while polymer processing volumes rose 7.5 percent year-on-year to 6,652 metric tonnes.
During the quarter, Shaily Engineering Plastics secured five new projects with three home furnishing customers and one new project in the automotive segment. In the healthcare division, the company signed four new projects across GLP-1 and other therapies and launched the Shaily Axiom Max fixed-dose pen. It also participated in global industry exhibitions such as CPHI Worldwide in Frankfurt, PDA Europe, and PODD Boston, holding more than 100 customer meetings for business development.
Healthcare revenue increased 163 percent year-on-year in the second quarter and 171 percent in the first half of the financial year, emerging as the key growth driver. On a consolidated basis, revenue for the quarter rose 34 percent to INR 256.7 crore, while earnings before interest, tax, depreciation and amortisation (EBITDA) nearly doubled to INR 81.6 crore and profit after tax increased 134 percent to INR 51.3 crore. EBITDA margins improved to 31.8 percent from 21.5 percent in the same period last year.
Fixed assets grew from INR 459.1 crore in March 2025 to INR 513.9 crore in September 2025, reflecting continued investment in new machinery and automation. Capital work-in-progress stood at INR 20.9 crore at the end of September 2025.
The company’s return on capital employed rose to 42.3 percent from 24.4 percent in March 2025, and its debt-to-equity ratio improved to 0.3 from 0.4. Credit rating agency CARE reaffirmed its A+ (Stable) rating on long-term bank facilities and A1 rating on short-term facilities.
Management stated that Shaily continues to add marquee customers across healthcare, consumer, and industrial segments while expanding export operations, which contributed over 70 percent of total revenue in the first half of financial year 2025–26.
Founded in 1987, Shaily Engineering Plastics Limited manufactures precision-engineered plastic and steel components for healthcare, consumer, and industrial applications. The company employs more than 2,000 people across its seven facilities in Gujarat.
